S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
Log in
LON:YGEN

Yourgene Health Share Forecast, Price & News

GBX 16.20
-0.18 (-1.07 %)
(As of 03/2/2021 02:02 PM ET)
Add
Compare
Today's Range
16
Now: GBX 16.20
16.60
50-Day Range
12.25
MA: GBX 14.39
17.13
52-Week Range
7
Now: GBX 16.20
24.55
Volume352,169 shs
Average Volume2.80 million shs
Market Capitalization£116.72 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, Europe, and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal test (NIPT) screening for pregnant women to estimate Down's syndrome and other genetic disorders. The IONA test enables clinical laboratories to perform their own NIPT screening service. It also offers Cystic Fibrosis screening test; genetic disease screening products; and reproductive health products that include polymerase chain reaction -based screening tests for male factor infertility, recurrent pregnancy loss, and thrombosis. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. The company was incorporated in 2000 and is headquartered in Manchester, the United Kingdom.

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone44 16 1667 6865
Employees136
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£17.03 million
Cash FlowGBX 1.89 per share
Book ValueGBX 6.50 per share

Profitability

Miscellaneous

Market Cap£116.72 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.69 out of 5 stars

Analyst Opinion: 0.0Community Rank: 1.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
GBX 16.20
-0.18 (-1.07 %)
(As of 03/2/2021 02:02 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive YGEN News and Ratings via Email

Sign-up to receive the latest news and ratings for YGEN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Yourgene Health (LON:YGEN) Frequently Asked Questions

What stocks does MarketBeat like better than Yourgene Health?

Wall Street analysts have given Yourgene Health a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Yourgene Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Yourgene Health's stock been impacted by Coronavirus?

Yourgene Health's stock was trading at GBX 14.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, YGEN stock has increased by 9.8% and is now trading at GBX 16.20.
View which stocks have been most impacted by COVID-19
.

Who are Yourgene Health's key executives?

Yourgene Health's management team includes the following people:
  • Mr. Lyn Dafydd Rees, CEO & Director (Age 47, Pay $219.74k)
  • Dr. Stephen Little, Exec. Vice Chairman (Age 64, Pay $66.75k)
  • Mr. Barry Hextall, CFO, Sec. & Exec. Director
  • Mr. Hayden William Jeffreys, COO & Director (Age 46, Pay $184.07k)
  • Dr. Chia-Han Chan, Chief Entrepreneur & Director (Age 45, Pay $154.48k)
  • Dr. Joanne Mason, Chief Scientific Officer & Director (Age 47)
  • Ms. Zoe Crookes, Legal Counsel
  • Ms. Joanne Cross, Director of Marketing
  • Dr. Robert Henke, VP of Sales - Global
  • Ms. Wendy Cox, HR Director

Who are some of Yourgene Health's key competitors?

What other stocks do shareholders of Yourgene Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Yourgene Health investors own include L'Air Liquide (AI), Cerus (CERS), Concepta PLC (CPT.L) (CPT), Alio Gold Inc. (ALO.TO) (ALO), Alamos Gold (AGI), African Gold Group, Inc. (AGG.V) (AGG), Alpha FX Group (AFX), Aminex (AEX), Agnico Eagle Mines (AEM) and Adobe (ADBE).

What is Yourgene Health's stock symbol?

Yourgene Health trades on the London Stock Exchange (LON) under the ticker symbol "YGEN."

How do I buy shares of Yourgene Health?

Shares of YGEN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Yourgene Health's stock price today?

One share of YGEN stock can currently be purchased for approximately GBX 16.20.

How much money does Yourgene Health make?

Yourgene Health has a market capitalization of £116.72 million and generates £17.03 million in revenue each year.

How many employees does Yourgene Health have?

Yourgene Health employs 136 workers across the globe.

What is Yourgene Health's official website?

The official website for Yourgene Health is www.yourgene-health.com.

How can I contact Yourgene Health?

The company can be reached via phone at 44 16 1667 6865.


This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.